The ERUDITE Study is evaluating the effectiveness of the investigational medication, luvadaxistat, in individuals with schizophrenia.
The purpose of this study is to understand whether the investigational medication is safe, how the body handles taking it (tolerability), and whether it works to improve cognitive function in study participants with schizophrenia.
You may Qualify if:
The total length of participation in the Erudite Study is
up to 72 weeks, which includes 12 on-site study visits and 9 telemedicine visits.
This study comprises the following periods: